Effectiveness and tolerance of topical nadifloxacin in the therapy of acne vulgaris (grade I-II): results of a non-interventional trial in 555 patients.
暂无分享,去创建一个
[1] J. Vila,et al. In vitro activity of nadifloxacin against several Gram-positive bacteria and analysis of the possible evolution of resistance after 2 years of use in Germany. , 2009, International Journal of Antimicrobial Agents.
[2] P. Nenoff. Acne vulgaris and bacterial skin infections: review of the topical quinolone nadifloxacin , 2006 .
[3] M. Jacobs,et al. Nadifloxacin: a quinolone for topical treatment of skin infections and potential for systemic use of its active isomer, WCK 771 , 2006, Expert opinion on pharmacotherapy.
[4] J. Fluhr,et al. Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid , 2006, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[5] K. T. Holland,et al. Clinical and bacteriological evaluation of nadifloxacin 1% cream in patients with acne vulgaris: a double-blind, phase III comparison study versus erythromycin 2% cream. , 2006, European journal of dermatology : EJD.
[6] P. Nenoff,et al. Activity of Nadifloxacin (OPC-7251) and Seven Other Antimicrobial Agents against Aerobic and Anaerobic Gram-Positive Bacteria Isolated from Bacterial Skin Infections , 2004, Chemotherapy.
[7] W J Cunliffe,et al. Antibiotic‐resistant acne: lessons from Europe , 2003, The British journal of dermatology.
[8] H. Gollnick,et al. Topical Treatment in Acne: Current Status and Future Aspects , 2003, Dermatology.
[9] J. Cove,et al. Prevalence of antibiotic‐resistant propionibacteria on the skin of acne patients: 10‐year surveillance data and snapshot distribution study , 2002, The British journal of dermatology.
[10] I. Kurokawa,et al. Susceptibility change to antibiotics of Staphylococcus aureus strains isolated from skin infections between July 1994 and November 2000 , 2002, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[11] B. Dréno,et al. Erythromycin-resistance of cutaneous bacterial flora in acne. , 2001, European journal of dermatology : EJD.
[12] T. Fujiwara,et al. Relationship between mutations in the DNA gyrase and topoisomerase IV genes and nadifloxacin resistance in clinically isolated quinolone-resistant Staphylococcus aureus , 2001, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.